Registration number: 03921089

Sensium Healthcare Limited

Contents

Balance Sheet	1
Notes to the Financial Statements	2 to 10

Sensium Healthcare Limited

(Registration number: 03921089)
Balance Sheet as at 31 December 2024

	Note	2024 £	2023 £
Fixed assets
Intangible assets	5	36,542	40,927
Tangible assets	6	-	8,858
		36,542	49,785
Current assets
Stocks	7	-	805,937
Debtors	8	4,345,205	2,370,465
Cash at bank and in hand		125,620	81,892
		4,470,825	3,258,294
Creditors: Amounts falling due within one year	9	(1,089,963)	(1,169,959)
Net current assets		3,380,862	2,088,335
Total assets less current liabilities		3,417,404	2,138,120
Creditors: Amounts falling due after more than one year	9	(10,480,845)	(5,958,616)
Net liabilities		(7,063,441)	(3,820,496)
Capital and reserves
Called up share capital	10	5,000	5,000
Share premium reserve		56,730,781	56,730,781
Retained earnings		(63,799,222)	(60,556,277)
Shareholders' deficit		(7,063,441)	(3,820,496)

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 30 September 2025 and signed on its behalf by:
 

......................................... Mr C R Bateman Director

Sensium Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
450 Bath Road
West Drayton
London
UB7 0EB

These financial statements were authorised for issue by the Board on 30 September 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

These financial statements have been prepared on a going concern basis which assumes the company will continue as a going concern for the foreseeable future, being a period of not less than 12 months from the date of approval of the financial statements.

The company relies on the continued financial support from The Surgical Company Holding B.V. (who own 100% of Track & Tigger B.V. NL who in turn own 100% of Sensium Healthcare Limited) to enable it to continue operating and meeting its liabilities as they fall due. Based on current forecasts for the company further funding is required during 2025 to support the activities being undertaken. The Surgical Company Holding B.V. have indicated their continuing support and combined with progress to date, the directors are of the opinion that sufficient funding will be available; for this reason the directors believe it is appropriate to prepare the accounts on a going concern basis.

Sensium Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Audit report

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 30 September 2025 was Benjamin Hayes BSc FCA, who signed for and on behalf of Wenn Townsend.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to the Statement of Comprehensive Income at the same rate as the depreciation on assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.

Grants of a revenue nature are recognised in the Statement of Comprehensive Income in the same period as the related expenditure.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Sensium Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Leasehold improvements	3 years
Plant and machinery	3 years
Fixtures, fittings and equipment	2 - 4 years

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Goodwill	10 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. Trade debtors are recognised at the transaction price, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Sensium Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities. Trade creditors are recognised at their transaction price.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 12 (2023 - 27).

Sensium Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

4	Loss before tax

Arrived at after charging/(crediting)

	2024 £	2023 £
Depreciation expense	4,539	12,054
Amortisation expense	4,385	2,923

5	Intangible assets

	Goodwill  £	Total £
Cost or valuation
At 1 January 2024	43,850	43,850
At 31 December 2024	43,850	43,850
Amortisation
At 1 January 2024	2,923	2,923
Amortisation charge	4,385	4,385
At 31 December 2024	7,308	7,308
Carrying amount
At 31 December 2024	36,542	36,542
At 31 December 2023	40,927	40,927

Sensium Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

6	Tangible assets

	Leasehold improvements £	Furniture, fittings and equipment  £	Total £
Cost or valuation
At 1 January 2024	173,117	749,886	923,003
Additions	-	91,179	91,179
Disposals	(173,117)	(841,065)	(1,014,182)
At 31 December 2024	-	-	-
Depreciation
At 1 January 2024	173,117	741,028	914,145
Charge for the year	-	4,539	4,539
Eliminated on disposal	(173,117)	(745,567)	(918,684)
At 31 December 2024	-	-	-
Carrying amount
At 31 December 2024	-	-	-
At 31 December 2023	-	8,858	8,858

7

Stocks

	2024 £	2023 £
Raw materials and consumables	761,490	805,937
Stock write-down	(761,490)	-
	-	805,937

Sensium Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

8

Debtors

	2024 £	2023 £
Trade debtors	49,302	52,752
Amounts owed by group undertakings and undertakings in which the company has a participating interest	3,438,379	1,598,183
Prepayments	857,524	708,992
Other debtors	-	10,538
	4,345,205	2,370,465

Sensium Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

9

Creditors

Creditors: amounts falling due within one year

	2024 £	2023 £
Due within one year
Trade creditors	105,015	166,931
Taxation and social security	36,036	56,706
Accruals and deferred income	948,912	946,322
	1,089,963	1,169,959

Creditors: amounts falling due after more than one year

	2024 £	2023 £
Due after one year
Owed by/(from) group undertakings	10,480,845	5,958,616